Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Nantel

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Pharmacology|January 1, 1990
Structure-activity study of neurokinins: antagonists for the neurokinin-2 receptorS Dion, N Rouissi, F Nantel, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2006
Triple VPI CGS 35601 reduces high blood pressure in low-renin, high-salt Dahl salt-sensitive ratsP Daull, A Blouin, K Belleville, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 29, 1996
CREM: a master-switch in the transcriptional response to cAMPM Lamas, L Monaco, E Zazopoulos, et al.
Drug and Chemical Toxicology|May 19, 2006
The first preclinical pharmacotoxicological safety assessment of CGS 35601, a triple vasopeptidase inhibitor, in chronically instrumented, conscious, and unrestrained spontaneously hypertensive ratsP Daull, R Lepage, O Benrezzak, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2006
The hemodynamic and metabolic profiles of Zucker diabetic fatty rats treated with a single molecule triple vasopeptidase inhibitor, CGS 35601P Daull, A Blouin, M Beaudoin, et al.
Brain Research|November 22, 2001
Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkeyS Lamontagne, E Meadows, P Luk, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Pharmacology|January 1, 1990
Structure-activity study of neurokinins: antagonists for the neurokinin-2 receptorS Dion, N Rouissi, F Nantel, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2006
Triple VPI CGS 35601 reduces high blood pressure in low-renin, high-salt Dahl salt-sensitive ratsP Daull, A Blouin, K Belleville, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 29, 1996
CREM: a master-switch in the transcriptional response to cAMPM Lamas, L Monaco, E Zazopoulos, et al.
Drug and Chemical Toxicology|May 19, 2006
The first preclinical pharmacotoxicological safety assessment of CGS 35601, a triple vasopeptidase inhibitor, in chronically instrumented, conscious, and unrestrained spontaneously hypertensive ratsP Daull, R Lepage, O Benrezzak, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2006
The hemodynamic and metabolic profiles of Zucker diabetic fatty rats treated with a single molecule triple vasopeptidase inhibitor, CGS 35601P Daull, A Blouin, M Beaudoin, et al.
Brain Research|November 22, 2001
Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkeyS Lamontagne, E Meadows, P Luk, et al.
Pageof 4